CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - 8-K Filing

Charles River Laboratories reports Q3 2026 organic revenue growth of 4.7% and raises full-year guidance following segment outperformance. (Items: 2.02 Results of Operations and Financial Condition On November 4, 2026, Charles River Laboratories International, Inc, 9.01 Financial Statements and Exhibits(d) Exhibits)

SEC EDGAR · November 4, 2026, 12:04 UTC

Tickers: $CRL

Read the full article at SEC EDGAR

Part of the story ILLINOIS TOOL WORKS INC - 8-K Filing (139 articles)

More Regulatory news

Newton Golf Company, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:14 UTC
XBiotech Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:53 UTC
Cohen & Co Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:48 UTC
UNITED BANCORP INC /OH/ - 10-Q Filing SEC EDGAR · November 12, 2026, 15:33 UTC
PATRIOT GOLD CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 15:32 UTC
First Digital Acquisition Corp Ltd. - 8-K Filing SEC EDGAR · November 12, 2026, 15:29 UTC
GROOVE BOTANICALS INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:24 UTC
Johnson Controls International plc - 10-K Filing SEC EDGAR · November 12, 2026, 15:24 UTC
OLD NATIONAL BANCORP /IN/ - 8-K Filing SEC EDGAR · November 12, 2026, 15:20 UTC
AMTECH SYSTEMS INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:16 UTC